Kessel, Christoph
McArdle, Angela
Verweyen, Emely
Weinhage, Toni
Wittkowski, Helmut
Pennington, Stephen R.
Foell, Dirk
Funding for this research was provided by:
Pfizer, Novartis, Sobi and Chugai-Roche
Article History
First Online: 14 July 2018
Compliance with Ethical Standards
:
: DF declares the receipt of research grant support and honoraria from Pfizer, Novartis, Sobi, and Chugai-Roche. The UCD Conway Institute and Proteomics Core is funded by the Programme for Research in Third level Institutions, as administered by Higher Education Authority of Ireland. Research in SRP’s lab is supported by grants from the Health Research Board, Enterprise Ireland and Science Foundation Ireland and previously including the EU funded FP7 MIAMI project. Dr. Pennington reports role as Founder and CSO of Atturos (ExternalRef removed) which is developing prostate cancer multiplexed protein biomarker test on MRM platform. Drs. Kessel and Foell have a patent “means and methods for diagnosing and treating inflammatory disorders” (WO 2016/178154 A1) issued to Muenster University. Dr. Foell has a patent “means and methods for diagnosing and treating inflammatory disorders” (WO 2016/178154 A1) issued to Muenster University. Angela McArdle, Emely Verweyen, Toni Weinhage, and Helmut Wittkowski declare that they have no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.